SOX4 and lung carcinoma: In vivo experiments demonstrated that, compared with control groups with stable knockdown of CASC15, concurrent overexpression of SOX4 significantly promoted tumor growth in nude mice bearing human lung carcinoma xenografts (Fig. 2i and Fig. S3).